Maximize pipeline value
Systematic identification of new commercial opportunities for your existing assets
Improve rate of success
Reduced development risk with mechanism-based responder stratification biomarkers
Get to market quicker
Deep mechanistic, FTO and regulatory insights into secondary indication potential
Gain additive revenue
Additive revenue potential from sunk R&D costs and recovery of stalled programs
Maximize pipeline value
Systematic identification of new commercial opportunities for your existing assets
Improve rate of success
Reduced development risk with mechanism-based responder stratification biomarkers
Get to market quicker
Deep mechanistic, FTO and regulatory insights into secondary indication potential
Gain additive revenue
Additive revenue potential from sunk R&D costs and recovery of stalled programs